超越阈值:连续肌酐变化与急性缺血性卒中血管内取栓术后的结局
基于CAN-REST登记研究(6638例、73个中心、16个国家、2023年)的二次分析,评估取栓术后48小时内肌酐变化与90天改良Rankin量表(mRS)及院内死亡的关系。结果显示肌酐升高与不良功能结局及死亡呈分级相关,效应在±10%的亚阈值变化即可检出,可补充二分类对比剂相关急性肾损伤(CA-AKI)框架。
要点
- 取栓术后48小时肌酐每增加1个对数比值单位,90天mRS不良偏移的校正共同比值比为1.48(95%CI 1.07–2.04)。
- 48小时肌酐升高10%即与更差功能结局(校正共同OR 1.04,95%CI 1.01–1.07)和死亡(校正OR 1.22,95%CI 1.13–1.32)相关。
- 48小时肌酐下降10%与两种结局的更低比值相关(功能结局校正共同OR 0.96,95%CI 0.93–0.99;死亡校正OR 0.74,95%CI 0.65–0.86)。
核心结论
- 取栓术后早期肌酐变化提供分级的、结局特异的预后信息,可延伸至正式CA-AKI阈值以下,变化幅度低至±10%即可检出剂量-反应关系,可补充二分类CA-AKI作为术后肾脏风险评估框架。
研究设计与样本
- CAN-REST登记研究(取栓术后对比剂相关肾病)的二次分析,为回顾性多中心观察性队列研究。
- 纳入2023年1月1日至12月31日在16个国家73个中心接受血管内取栓治疗的急性缺血性卒中成人6638例。
- 早期肌酐变化以48小时肌酐与基线肌酐比值的自然对数(ln[48小时/基线肌酐])量化,CA-AKI按肾脏病改善全球结局(KDIGO)标准定义(48小时内≥0.3 mg/dL或≥基线1.5倍升高)。
- 采用多变量logistic回归校正预设基线与围手术期协变量,线性与限制性立方样条模型由似然比检验选择,对比在±10%、±25%、±50%处估计。
- 注册号NCT06596603(ClinicalTrials.gov)。
主要发现
- 48小时内肌酐加重与90天mRS不良偏移独立相关(每1单位对数比值增加,校正共同OR 1.48,95%CI 1.07–2.04;线性)。
- 肌酐加重与院内死亡相关,呈非线性剂量-反应,幅度更大。
- 48小时肌酐升高10%与更差功能结局相关(校正共同OR 1.04,95%CI 1.01–1.07),并与死亡相关(校正OR 1.22,95%CI 1.13–1.32)。
- 48小时肌酐下降10%与两种结局的更低的比值相关(功能结局校正共同OR 0.96,95%CI 0.93–0.99;死亡校正OR 0.74,95%CI 0.65–0.86)。
- 功能结局关联集中于mRS较高切点(严重残疾、死亡);基线肾功能对该关联的效应修饰不显著。
关键数值与推荐
- CA-AKI定义采用KDIGO标准:48小时内肌酐≥0.3 mg/dL或≥基线1.5倍升高。
- 早期肌酐变化指标为ln(48小时肌酐/基线肌酐)。
- 对比估计点为±10%、±25%、±50%的肌酐变化。
- 48小时肌酐升高10%:功能结局校正共同OR 1.04(95%CI 1.01–1.07),死亡校正OR 1.22(95%CI 1.13–1.32)。
- 48小时肌酐下降10%:功能结局校正共同OR 0.96(95%CI 0.93–0.99),死亡校正OR 0.74(95%CI 0.65–0.86)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Stroke, Volume 57, Issue 11, Page 3292-3305, November 1, 2026. BACKGROUND:Contrast-associated acute kidney injury (CA-AKI) after endovascular thrombectomy (EVT) worsens outcomes in acute ischemic stroke, but threshold-based definitions do not capture prognostic information from subthreshold changes. We tested whether early creatinine change within 48 hours of EVT conveys graded prognostic information beyond dichotomous CA-AKI.METHODS:We performed a secondary analysis of the CAN-REST registry (Contrast-Associated Nephropathy After Endovascular Stroke Treatment), a retrospective multicenter observational cohort study of 6638 EVT-treated adults with acute ischemic stroke enrolled at 73 centers in 16 countries between January 1 and December 31, 2023. Early creatinine change was quantified as the natural logarithm ratio of 48-hour creatinine to baseline creatinine (ln[48-hour/baseline creatinine]), with CA-AKI defined per Kidney Disease: Improving Global Outcomes criteria (≥0.3 mg/dL or ≥1.5× baseline rise within 48 hours). Multivariable logistic regression adjusted for prespecified baseline and periprocedural covariates examined associations with 90-day modified Rankin Scale shift and in-hospital mortality; linear versus restricted cubic spline specification was selected by likelihood ratio testing, and contrasts were estimated at ±10%, ±25%, and ±50%.RESULTS:Greater creatinine worsening within 48 hours of EVT was independently associated with an unfavorable 90-day modified Rankin Scale shift (adjusted common odds ratio per 1-unit log-ratio increase, 1.48 [95% CI, 1.07–2.04]; linear) and in-hospital mortality (nonlinear dose-response, of larger magnitude). A 10% increase in creatinine at 48 hours—well below Kidney Disease: Improving Global Outcomes threshold—was associated with worse functional outcome (adjusted common odds ratio, 1.04 [95% CI, 1.01–1.07]) and death (adjusted odds ratio, 1.22 [95% CI, 1.13–1.32]); a 10% decrease in creatinine at 48 hours was associated with lower odds of both outcomes (adjusted common odds ratio, 0.96 [95% CI, 0.93–0.99]; adjusted odds ratio, 0.74 [95% CI, 0.65–0.86]). The functional-outcome association concentrated at upper modified Rankin Scale cut-points (severe disability, death); effect modification by baseline renal function was not significant.CONCLUSIONS:Early creatinine change after EVT conveys graded, outcome-specific prognostic information extending below formal CA-AKI thresholds, with a dose-response detectable at changes as modest as ±10%, complementing binary CA-AKI as a framework for post-EVT renal risk assessment. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT06596603.
引用
- Stroke:Beyond the Threshold: Continuous Creatinine Change and Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。